Stockscreener 앱 받기
1.87
0.53%
-0.010
시간 외 거래:
1.85
-0.02
-1.07%
전일 마감가:
$1.88
열려 있는:
$1.86
하루 거래량:
139.43K
Relative Volume:
0.15
시가총액:
$58.05M
수익:
$8.59M
순이익/손실:
$-17.07M
주가수익비율:
-3.0656
EPS:
-0.61
순현금흐름:
$-21.90M
1주 성능:
+1.91%
1개월 성능:
+199.68%
6개월 성능:
+146.05%
1년 성능:
+27.21%
1일 변동 폭
$1.86
$1.8799
1주일 범위
$1.82
$1.89
52주 변동 폭
$0.4801
$2.64
Durect Corp Stock (DRRX) Company Profile
명칭
Durect Corp
전화
(408) 777-1417
주소
10240 BUBB ROAD, CUPERTINO, CA
DRRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRRX
Durect Corp
|
1.87 | 57.74M | 8.59M | -17.07M | -21.90M | -0.61 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-10-30 | 개시 | Chardan Capital Markets | Buy |
| 2020-10-12 | 개시 | ROTH Capital | Buy |
| 2020-07-31 | 개시 | Oppenheimer | Outperform |
| 2020-01-31 | 개시 | B. Riley FBR | Buy |
| 2019-11-18 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-09-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-03-06 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2017-10-20 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2017-10-20 | 재확인 | Laidlaw | Buy |
| 2017-10-20 | 다운그레이드 | Stifel | Buy → Hold |
| 2017-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2017-02-28 | 재개 | H.C. Wainwright | Buy |
| 2016-04-25 | 개시 | Rodman & Renshaw | Buy |
| 2015-05-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2015-05-01 | 재확인 | Stifel | Buy |
| 2013-03-25 | 개시 | Stifel | Buy |
| 2012-11-01 | 다운그레이드 | C.K. Cooper | Buy → Hold |
| 2012-08-17 | 개시 | C.K. Cooper | Buy |
| 2009-06-23 | 개시 | Caris & Company | Buy |
| 2009-03-26 | 개시 | Wedbush Morgan | Hold |
모두보기
Durect Corp 주식(DRRX)의 최신 뉴스
Reversal indicators forming on DURECT Corporation stockTrend Following Ideas with Volume Confirmation - Newser
DURECT (DRRX) Projected to Post Quarterly Earnings on Tuesday - Defense World
Signal strength of DURECT Corporation stock in tech scannersReal-Time Entry Forecast with Accuracy Metrics - Newser
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Insider Monkey
Market reaction to DURECT Corporation’s recent newsFree Swing Setup With Technical Confirmation - Newser
Using R and stats models for DURECT Corporation forecastingAlpha Generation Strategy with Low Volatility - Newser
Is DURECT Corporation reversing from oversold territoryWeekly Return Plan for Conservative Traders - Newser
Visualizing DURECT Corporation stock with heatmapsDay Trading Plan with Entry Risk Management - Newser
What is DURECT Corporation company’s growth strategyFree Investment Community - Jammu Links News
Can volume confirm reversal in DURECT CorporationSmart Forecast Signals from AI Models - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - Eastern Progress
What makes DURECT Corporation stock price move sharplyRisk/Reward Optimization Entry Point Analysis - Newser
Can swing trading help recover from DURECT Corporation lossesFree Accurate Buy Point for Momentum Stocks - Newser
Does DURECT Corporation show high probability of reboundMarket Correction Proof Stock Screening Analysis - Newser
Bausch Health files SC TO-C ahead of tender offer for DURECT (DRRX) | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health expands liver disease portfolio with DURECT Corp buy - The Pharma Letter
What does recent volatility data suggest for DURECT CorporationLow Risk High Confidence Watchlist Builder - Newser
Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN
Durect Corp: Analyzing DRRX Stock Trends - investchronicle.com
Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside - FinancialContent
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - inkl
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views - Benzinga
Bausch Health to buy Durect for $63M upfront; Fulcrum’s Ph1b sickle cell data - Endpoints News
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings - Benzinga
Bausch Health stock rises, Durect flies after acquisition deal By Investing.com - Investing.com Canada
Bausch Health stock rises, Durect flies after acquisition deal - Investing.com
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders - Business Wire
Durect stock rises on M&A deal with Bausch Health (BHC:NYSE) - Seeking Alpha
DRRX to be acquired by Bausch for $1.75 cash + CVR worth up to $350M | DRRX SEC FilingForm 8-K - Stock Titan
Bausch Health To Acquire DURECT; Expanding Liver Disease Pipeline With Larsucosterol - Nasdaq
Bausch Health to acquire DURECT in $63 million deal for liver disease drug - Investing.com Canada
Bausch Health to acquire DURECT for $63 million upfront By Investing.com - Investing.com Canada
Bausch Health to launch tender offer for DURECT; Schedule TO-C filed | DRRX SEC FilingForm SC TO-C - Stock Titan
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - PR Newswire
When is the best time to exit AA Mission Acquisition Corp.Free Community Shared Smart Money Signals - Newser
Is ICF International Inc. stock overhyped or has real potentialFree Low Risk Buy Zone Opportunity Watch - Newser
How Aeries Technology Inc Equity Warrant stock performs during market volatilityFree Accurate Technical Trend Reversal Picks - Newser
Short Term Trend Reversal in DURECT Corporation PossibleLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
How to forecast Kornit Digital Ltd. trends using time seriesBreakout Monitoring with Momentum Analysis - Newser
Is it the right time to buy DURECT Corporation stockIdentify breakout stocks before they peak - Jammu Links News
How Interest Rate Changes Impact CCSI Stock PerformanceLow Risk ROI Maximization - Newser
What makes Atlantic Union Bankshares Corporation stock price move sharplyFree VIP Investment Strategies - Newser
Moving Average Trends for DURECT Corporation Stock: What They IndicateWealth Building Stock Portfolio - Newser
What makes BBUC stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
Why DURECT Corporation stock attracts strong analyst attentionFree Exclusive Group - Newser
Why Visionary Holdings Inc. stock attracts strong analyst attentionLow Risk Scalping Alerts - Newser
What makes Bio Techne Corporation stock price move sharplyTop Rated Trade Entries - Newser
Is DURECT Corporation a good long term investmentUnmatched market performance - PrintWeekIndia
What analysts say about DURECT Corporation stockSuperior capital gains - PrintWeekIndia
What analysts say about Bowen Acquisition Corp stockLightning-fast capital gains - PrintWeekIndia
Does Veren Inc. stock pay reliable dividendsConsistently exceptional gains - jammulinksnews.com
Durect Corp (DRRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):